ELEVANCE HEALTH INC (1ANTM.MI) Stock Analyst Earnings Estimates
BIT:1ANTM - Euronext Milan - US0367521038 - Common Stock - Currency: EUR
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 156.595B 12.95% | 171.34B 9.42% | 176.81B 3.19% | 194.686B 10.11% | 208.842B 7.27% | 228.68B 9.50% | N/A | N/A | N/A | N/A | N/A | |
| EBITDA YoY % growth | 10.165B -2.79% | 11.242B 10.60% | 10.549B -6.16% | 11.634B 10.29% | 13.026B 11.96% | 14.429B 10.77% | 16.044B 11.19% | 16.836B 4.94% | 17.704B 5.16% | 18.669B 5.45% | 19.623B 5.11% | |
| EBIT YoY % growth | 8.49B -7.26% | 9.497B 11.86% | 9.156B -3.59% | 10.947B 19.56% | 12.162B 11.10% | 16.126B 32.59% | N/A | N/A | N/A | N/A | N/A | |
| Operating Margin | 5.42% | 5.54% | 5.18% | 5.62% | 5.82% | 7.05% | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | 29.05 11.86% | 33.11 13.98% | 32.97 -0.42% | 34.49 4.61% | 39.44 14.36% | 46.37 17.55% | 56.99 22.92% | 64.05 12.39% | 71.86 12.19% | 82.33 14.56% | 93.88 14.04% |
All data in USD
| Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 10.75 1.05% | 10.30 1.75% | 8.67 3.57% | 4.70 22.47% | 12.60 17.17% | 11.74 14.05% | 9.83 13.38% | 5.68 20.72% | 14.00 11.11% | 12.96 10.34% | 11.48 16.78% | 6.16 8.43% |
| Revenue Q2Q % growth | 46.515B 9.25% | 48.143B 11.38% | 49.513B 10.72% | 49.919B 10.96% | 49.889B 7.25% | 51.583B 7.15% | 52.901B 6.84% | 52.989B 6.15% | 54.734B 9.71% | 55.482B 7.56% | 55.612B 5.12% | 55.872B 5.44% |
| EBITDA Q2Q % growth | 3.442B -2.63% | 3.311B -10.32% | 2.871B -3.50% | 1.739B -25.65% | 4.148B 20.51% | 3.674B 10.96% | 3.198B 11.39% | 1.978B 13.74% | 4.521B 8.99% | 4.05B 10.23% | 3.557B 11.23% | 2.258B 14.16% |
| EBIT Q2Q % growth | 3.373B 5.27% | 3.17B 4.76% | 2.714B 37.07% | 1.42B 50.11% | 3.926B 16.39% | 3.622B 14.26% | 3.19B 17.54% | 1.847B 30.07% | 4.361B 11.08% | 3.889B 7.37% | 3.394B 6.39% | 2.092B 13.26% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2024 Q2Q % growth | 3.84 -31.67% | 3.83 | 0.01 | 0.17% |
| Q3 2024 Q2Q % growth | 8.37 -6.90% | 9.76 | -1.39 | -14.20% |
| Q2 2024 Q2Q % growth | 10.12 11.95% | 10.11 | 0.01 | 0.10% |
| Q1 2024 Q2Q % growth | 10.64 12.47% | 10.64 | 0.00 | 0.03% |
| Q4 2023 Q2Q % growth | 5.62 7.46% | 5.70 | -0.08 | -1.40% |
| Q3 2023 Q2Q % growth | 8.99 19.39% | 8.52 | 0.47 | 5.47% |
| Q2 2023 Q2Q % growth | 9.04 12.44% | 8.88 | 0.16 | 1.75% |
| Q1 2023 Q2Q % growth | 9.46 14.67% | 9.35 | 0.11 | 1.13% |
| Q4 2022 Q2Q % growth | 5.23 1.75% | 5.24 | -0.01 | -0.20% |
| Q3 2022 Q2Q % growth | 7.53 10.90% | 7.22 | 0.31 | 4.30% |
| Q2 2022 Q2Q % growth | 8.04 14.37% | 7.82 | 0.22 | 2.84% |
| Q1 2022 Q2Q % growth | 8.25 17.69% | 7.89 | 0.36 | 4.54% |
| Q4 2021 Q2Q % growth | 5.14 102.36% | 5.16 | -0.02 | -0.46% |
| Q3 2021 Q2Q % growth | 6.79 61.67% | 6.43 | 0.36 | 5.53% |
| Q2 2021 Q2Q % growth | 7.03 -23.59% | 6.40 | 0.63 | 9.93% |
| Q1 2021 Q2Q % growth | 7.01 8.18% | 6.58 | 0.43 | 6.57% |
| Q4 2020 Q2Q % growth | 2.54 -34.54% | 2.55 | -0.01 | -0.21% |
| Q3 2020 Q2Q % growth | 4.20 -13.76% | 4.19 | 0.01 | 0.15% |
| Q2 2020 Q2Q % growth | 9.20 98.28% | 8.96 | 0.24 | 2.64% |
| Q1 2020 Q2Q % growth | 6.48 7.46% | 6.54 | -0.06 | -0.94% |
| Q4 2019 Q2Q % growth | 3.88 | 3.92 | -0.04 | -1.06% |
| Q3 2019 Q2Q % growth | 4.87 | 4.87 | 0.00 | 0.03% |
| Q2 2019 Q2Q % growth | 4.64 | 4.66 | -0.02 | -0.43% |
| Q1 2019 Q2Q % growth | 6.03 | 5.87 | 0.16 | 2.68% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2024 Q2Q % growth | 44.989B 5.49% | 45.311B | -322M | -0.71% |
| Q3 2024 Q2Q % growth | 44.719B 4.36% | 43.8B | 919M | 2.10% |
| Q2 2024 Q2Q % growth | 43.223B -1.03% | 43.485B | -262M | -0.60% |
| Q1 2024 Q2Q % growth | 42.577B 0.96% | 43.052B | -475M | -1.10% |
| Q4 2023 Q2Q % growth | 42.647B 6.81% | 42.466B | 181M | 0.43% |
| Q3 2023 Q2Q % growth | 42.849B 7.29% | 43.042B | -193M | -0.45% |
| Q2 2023 Q2Q % growth | 43.672B 13.05% | 41.917B | 1.755B | 4.19% |
| Q1 2023 Q2Q % growth | 42.172B 10.70% | 41.24B | 932M | 2.26% |
| Q4 2022 Q2Q % growth | 39.929B 9.15% | 40.038B | -109M | -0.27% |
| Q3 2022 Q2Q % growth | 39.939B 11.49% | 39.479B | 460M | 1.17% |
| Q2 2022 Q2Q % growth | 38.632B 14.12% | 38.51B | 122M | 0.32% |
| Q1 2022 Q2Q % growth | 38.095B 17.63% | 37.727B | 368M | 0.98% |
| Q4 2021 Q2Q % growth | 36.581B 15.18% | 36.878B | -297M | -0.81% |
| Q3 2021 Q2Q % growth | 35.822B 14.90% | 35.652B | 170M | 0.48% |
| Q2 2021 Q2Q % growth | 33.851B 15.72% | 33.536B | 315M | 0.94% |
| Q1 2021 Q2Q % growth | 32.385B 9.12% | 33.272B | -887M | -2.67% |
| Q4 2020 Q2Q % growth | 31.76B 15.81% | 31.089B | 671M | 2.16% |
| Q3 2020 Q2Q % growth | 31.176B 16.82% | 30.111B | 1.065B | 3.54% |
| Q2 2020 Q2Q % growth | 29.253B 14.84% | 29.542B | -289M | -0.98% |
| Q1 2020 Q2Q % growth | 29.678B 20.27% | 28.885B | 793M | 2.75% |
| Q4 2019 Q2Q % growth | 27.424B | 27.368B | 56M | 0.20% |
| Q3 2019 Q2Q % growth | 26.687B | 26.134B | 553M | 2.12% |
| Q2 2019 Q2Q % growth | 25.473B | 25.12B | 353M | 1.41% |
| Q1 2019 Q2Q % growth | 24.676B | 24.463B | 213M | 0.87% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 3.29% | N/A | -2.33% | N/A |
| Revenue | 1.19% | N/A | 2.22% | N/A |